Historical Stock Price
ETFs Holding LXRX »    LXRX Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $2.12 $2.26 $2.10 $2.26 299.60K
12/05/2022 $2.24 $2.24 $2.10 $2.16 382.50K
12/06/2022 $2.18 $2.19 $2.09 $2.11 206.20K
12/07/2022 $2.12 $2.13 $2.06 $2.07 327.30K
12/08/2022 $2.11 $2.20 $2.05 $2.17 234.10K
Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs.
LXRX historical stock prices picture
Lexicon Pharmaceuticals (LXRX) has the following price history information. Looking back at LXRX historical stock prices for the last five trading days, on December 02, 2022, LXRX opened at $2.12, traded as high as $2.26 and as low as $2.10, and closed at $2.26. Trading volume was a total of 299.60K shares. On December 05, 2022, LXRX opened at $2.24, traded as high as $2.24 and as low as $2.10, and closed at $2.16. Trading volume was a total of 382.50K shares. On December 06, 2022, LXRX opened at $2.18, traded as high as $2.19 and as low as $2.09, and closed at $2.11. Trading volume was a total of 206.20K shares. On December 07, 2022, LXRX opened at $2.12, traded as high as $2.13 and as low as $2.06, and closed at $2.07. Trading volume was a total of 327.30K shares. On December 08, 2022, LXRX opened at $2.11, traded as high as $2.20 and as low as $2.05, and closed at $2.17. Trading volume was a total of 234.10K shares.

LXRX Historical Stock Prices By Date:

LXRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Lexicon Pharmaceuticals shares, starting with a $10,000 purchase of LXRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $12.25
End price/share: $2.17
Dividends collected/share: $0.00
Total return: -82.29%
Average Annual Total Return: -15.90%
Starting investment: $10,000.00
Ending investment: $1,770.79
Years: 10.00
Date Close
12/02/2022$2.26
12/05/2022$2.16
12/06/2022$2.11
12/07/2022$2.07
12/08/2022$2.17
LXRX is categorized under the Healthcare sector; below are some other companies in the same sector:

MACK Historical Stock Prices
MAKO Historical Stock Prices
MASI Historical Stock Prices
MATN Historical Stock Prices
MAXY Historical Stock Prices
MBIO Historical Stock Prices
MBOT Historical Stock Prices
MBRX Historical Stock Prices
MBVX Historical Stock Prices
MCK Historical Stock Prices

Also explore: LXRX shares outstanding history

Email EnvelopeFree LXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

LXRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.